Clinical Trial Update: Colposeptine for the Treatment of Bacterial Vaginosis [Phase 4]

View source ↗

Summary

Phase 4 trial of Colposeptine for bacterial vaginosis was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Colposeptine

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Vaginosis, Bacterial | Phase 4 | Status: TERMINATED | Results posted: 2012-08-21